MedAvante, a provider of centralized assessments and quality control in clinical trials of treatments for central nervous system (CNS) disorders, announced the Virgil Investigative Study Platform for use by drug developers and their global cohort of trial sites. It allows clinicians at investigative sites to standardize rating scale administration and scoring across trials. Virgil software ranges from  electronic rating scale forms, which provide clinical guidance to site raters as they administer an assessment, to  operational workflows throughout the study process.

News

MedAvanta offers software that guides investigative sites in rater reliability skills.